About arterial hypertension against the background of a new coronavirus infection

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Data are presented on the features of the course of a new coronavirus infection COVID-19 in patients with cardiovascular diseases and, in particular, with arterial hypertension, as well as on a higher incidence of adverse outcomes in this group of patients. The article touches upon information about additional risks in patients with arterial hypertension against the background of coronavirus infection, including those associated with antihypertensive therapy, and approaches to the management of such patients.

Full Text

Restricted Access

About the authors

D. A. Alikberova

52nd Consultative and Diagnostic Center, Ministry of Defense of the Russian Federation

Author for correspondence.
Email: Alikberova72@bk.ru
Russian Federation, Moscow

L. E. Khachaturyan

52nd Consultative and Diagnostic Center, Ministry of Defense of the Russian Federation

Email: Alikberova72@bk.ru
Russian Federation, Moscow

L. A. Tsedenova

52nd Consultative and Diagnostic Center, Ministry of Defense of the Russian Federation

Email: Alikberova72@bk.ru
Russian Federation, Moscow

O. I. Didenko

52nd Consultative and Diagnostic Center, Ministry of Defense of the Russian Federation

Email: Alikberova72@bk.ru
Russian Federation, Moscow

References

  1. Громова О.А., Торшин И.Ю. Важность цинка для поддержания активности белков врожденного противовирусного иммунитета: анализ публикаций, посвященных COVID-19 // Профилакт. медицина. – 2020. – Т. 23, № 3. – С. 131–139.
  2. Коростовцева Л.С., Ротарь О.П., Конради А.О. COVID-19: каковы риски пациентов с артериальной гипертензией? // Артериальная гипертензия. – 2020. – Т. 26, № 2. – С. 124–132.
  3. Сулигбурская Ю., Богданский П., Шулинска М., Пупек-Мусиалик Д. Влияние антигипертензивных препаратов на минеральный статус у больных артериальной гипертензией // Европейский обзор мед. и фармакол. наук. – 2014. – Т. 18, № 1. – С. 58–65.
  4. Шляхто Е.В., Конради А.О., Арутюнов Г.П. и др. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19 // Рос. кардиол. журн. – 2020. – Т. 25, № 3. – С. 129–148.
  5. Guo T., Fan Y., Chen M. et al. Cardiovascular Implcations of Fatal Outcomes of Patients With Coronavirus Dsease 2019 (COVID-19) // JAMA cardiol. – 2020. – Vol. 5, N 7. – P. 811–818.
  6. Prasad A.S., Beck F.W.J., Bao B. et al. Zinc supplementation decreases incidence ofinfections in the elderly: Effect of zinc on generation of cytokines and oxidative stress // Am. J. Clin. Nutr. – 2007. – Vol. 85, N 3. – P. 837–844.
  7. Wang L., He W., Yu X. et al. Coronavirus Disease 2019 in elderly рatients: characteristics and prognostic factors based on 4-week follow-up // J. Infection. – 2020. – Vol. 80, Iss. 6. – P. 639–645.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Alikberova D.A., Khachaturyan L.E., Tsedenova L.A., Didenko O.I.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies